2004
Adherence to conventional and atypical antipsychotics after hospital discharge.
Diaz E, Neuse E, Sullivan MC, Pearsall HR, Woods SW. Adherence to conventional and atypical antipsychotics after hospital discharge. The Journal Of Clinical Psychiatry 2004, 65: 354-60. PMID: 15096075, DOI: 10.4088/jcp.v65n0311.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntipsychotic AgentsBenzodiazepinesDiagnostic and Statistical Manual of Mental DisordersDrug Administration ScheduleFeasibility StudiesFemaleHospitalizationHospitals, PsychiatricHumansMaleOlanzapinePatient CompliancePatient DischargePilot ProjectsProspective StudiesRisperidoneSchizophreniaConceptsConventional antipsychoticsMedication adherenceDose frequencyHospital dischargeAtypical antipsychoticsSchizoaffective disorderUsual care providersBetter medication adherenceMedication adherence ratesSeverity of illnessShort-term adherenceDSM-IV diagnosisDiagnosis of schizophreniaAdherence advantageElectronic adherence monitorsOral antipsychoticsUsual careProspective studyAdherence ratesOutcome measuresMedication analysisAdherence monitorsAntipsychoticsCare providersInpatient unit
2001
Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia.
Diaz E, Levine HB, Sullivan MC, Sernyak MJ, Hawkins KA, Cramer JA, Woods SW. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. Journal Of Psychiatry And Neuroscience 2001, 26: 325-9. PMID: 11590972, PMCID: PMC167186.Peer-Reviewed Original ResearchConceptsMedication Event Monitoring SystemEvent Monitoring SystemFirst monthMedication complianceSchizoaffective disorderCompliance rateTypical antipsychotic treatmentMean compliance ratePsychiatric inpatient hospitalHospital readmission dataElectronic monitoring devicesConsecutive patientsMedication regimensMonth 3Antipsychotic treatmentReadmission dataInpatient hospitalPatientsMEMS capsSchizophrenic disordersBottle openingHospitalSchizophreniaMonthsDisorders
2000
Characteristics of Participants and Nonparticipants in Medication Trials for Treatment of Schizophrenia
Woods SW, Ziedonis DM, Sernyak MJ, Diaz E, Rosenheck RA. Characteristics of Participants and Nonparticipants in Medication Trials for Treatment of Schizophrenia. Psychiatric Services 2000, 51: 79-84. PMID: 10647137, DOI: 10.1176/ps.51.1.79.Peer-Reviewed Original ResearchConceptsSubstance use disordersTreatment of schizophreniaUse disordersAdministrative databasesEfficacy trialsTrial participantsDual diagnosisConcurrent substance use disordersCommunity mental health centerTreatment Efficacy TrialCharacteristics of patientsPoor treatment outcomesMental health centersCharacteristics of participantsMedical comorbiditiesMedication trialsTypes of trialsMale genderHealth centersService utilizationTreatment outcomesBetter outcomesPatientsTreatment efficacyYounger age